eNewsroom for: InnFocus Inc.

News from InnFocus Inc.:

InnFocus Expands Board of Directors and Responsibilities

Current Director Randy Lindholm Named Chair; Tim Willis Joins Board MIAMI, April 16, 2015 /PRNewswire/ — InnFocus, Inc. reports Director Randy Lindholm has been named Chairman of the Board. Mr. Lindholm was previously Chairman of the Board and CEO of Vidamed, until it was acquired by Medtroni…

InnFocus FDA Phase One Enrollment Reaches 75 Patient Filing Milestone

InnFocus MicroShunt Glaucoma Drainage Implant Showing Promising Results in Other Studies MIAMI, April 13, 2015 /PRNewswire/ — InnFocus Inc. reports that treatments for its U.S. Food and Drug Administration (FDA) Phase One clinical trial of the InnFocus MicroShunt® glaucoma drainage imp…

InnFocus MicroShunt® Glaucoma Series Of 82 Patients Show Excellent Results

SAN FRANCISCO, Feb. 9, 2015 /PRNewswire/ — InnFocus Inc. Chief Executive Officer Russ Trenary reports on a series of 82 patients that have been implanted with the InnFocus MicroShunt® outside the United States. The patients experienced a mean reduction in Intraocular Pressure (IOP) from a p…

First Glaucoma Patients Treated in Spain Using InnFocus MicroShunt®

MIAMI, Jan. 20, 2015 /PRNewswire/ — InnFocus, Inc. reports that the first surgeries using the InnFocus MicroShunt® glaucoma drainage implant in Spain have been successfully conducted. Two surgeries were performed at the Hospital Clinico San Carlos in Madrid, Spain. Photo – htt…

InnFocus MicroShunt® Continues to Show Excellent Results

CEO Tells San Francisco Forum That It Treats the Largest Glaucoma Patient Segment SAN FRANCISCO, Jan. 12, 2015 /PRNewswire/ — InnFocus, Inc. reports the InnFocus MicroShunt® has now been used in more than 100 glaucoma surgeries worldwide, in the current configuration and surgical technique,…

InnFocus Featured at the Ophthalmology Innovation Summit In Chicago

InnFocus MicroShunt® showing promising results in reducing IOP in glaucoma patients. CHICAGO, Oct. 17, 2014 /PRNewswire/ — InnFocus, Inc., reported on results of 59 glaucoma patients treated outside the United States for up to 3 years with the InnFocus MicroShunt® at the 2014 Ophthalmolo…

InnFocus MicroShunt™ Shows Promising Glaucoma Results at ESCRS

IOP Levels Stable and Below 14mmHG after one year in another series MIAMI, Sept. 22, 2014 /PRNewswire/ — InnFocus, Inc. reported today that it shared one year results from 34 patients treated, utilizing the current surgical technique for the InnFocus MicroShunt ™ glaucoma drainage implant, a…

First Surgery in Japan Using InnFocus MicroShunt™

Shirato Eye Clinic of Tokyo is first Japanese center to use the MicroShunt for Glaucoma MIAMI, Sept. 10, 2014 /PRNewswire/ — InnFocus, Inc. reported today that the first two surgeries have been conducted in Japan in a clinical investigational study using the InnFocus MicroShunt™ glaucoma d…

Russ Trenary to Lead InnFocus, Inc.

Veteran Ophthalmology Executive Will Guide Development and Approval of Exciting New Glaucoma Surgical Device. MIAMI, Oct. 1, 2013 /PRNewswire/ — Russ Trenary has been named President and Chief Executive Officer of Miami-based InnFocus, Inc., a privately held medical device company w…